| Alternative Name: | Abelson murine leukemia viral oncogene homolog 1 |
| |
| Sequence: | Human recombinant Abl1 (aa 27-1130) with N-terminal histidine tag. |
| |
| MW: | ~135kDa |
| |
| Source: | Produced in insect cells. Produced in a baculovirus expression system. |
| |
| UniProt ID: | P00519 |
| |
| Formulation: | Liquid. In 50mM sodium phosphate, pH 7.0, containing 300mM NaCl, 150mM imidazole, 0.1mM PMSF, 0.25mM DTT, 25% glycerol. |
| |
| Purity: | ≥70% (SDS-PAGE) |
| |
| Application Notes: | Useful tool to study enzyme regulation and kinetics, phosphorylate target substrates, screen for inhibitors. |
| |
| Shipping: | Shipped on Dry Ice |
| |
| Long Term Storage: | -80°C |
| |
| Handling: | Avoid freeze/thaw cycles. |
| |
| Scientific Background: | The ABL1 protooncogene encodes a cytoplasmic and nuclear protein tyrosine kinase that has been implicated in cell differentiation, cell division, cell adhesion, and stress responses. The c-Abl protein is inhibited by its SH3 domain, and deletion of this domain turns ABL1 into an oncogene. A chromosomal translocation results in the head-to-tail fusion of the BCR and ABL1 genes. This translocation is present in many cases of chronic myelogeneous leukemia. The DNA-binding activity of Abl1 is regulated by CDC2-mediated phosphorylation. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
